Benralizumab
D3251C00014
Phase 3 mab completed
Quick answer
Benralizumab for Chronic Obstructive Pulmonary Disease is a Phase 3 program (mab) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Chronic Obstructive Pulmonary Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- completed